Clinical Trial Update: SYSTANE® PRO vs. MIEBO™ in Dry Eye Disease [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial is evaluating SYSTANE PRO versus MIEBO for dry eye disease, with recruitment currently ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dry Eye Disease

Drugs mentioned

• Miebo (perfluorohexyloctane ophthalmic solution)
• Systane PRO

Snippet

Sponsor: Indiana University | Conditions: Dry Eye Disease (DED) | Phase 4 | Status: RECRUITING